Probiotic Safety Latest Target Of Supplement Regulation Critic Cohen
This article was originally published in The Rose Sheet
Executive Summary
More extensive labeling for probiotics and more stringent GMPs for live microorganism production already are required in Canada, says physician and researcher Pieter Cohen in JAMA Internal Medicine. "Consumers and physicians should not assume that the label on probiotic supplements provides adequate information to determine if consuming the live microorganism is worth the risk," he says.
You may also be interested in...
Novartis Wins Second Landmark German Case, This Time For Probiotics
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
Metric Weights For Probiotics Mislead But CFUs Inform, Say Industry Groups
Council for Responsible Nutrition, Consumer Healthcare Products Association and Natural Products Association urge FDA to allow colony forming units on probiotic product labels while nixing current labeling regulation’s allowance of metric weight, as the measurement does not reflect live microbials.
FDA Regulatory Oversight No Impediment To Drug-Spiked Supplements, Study Finds
Products marketed for sexual enhancement or weight loss remain the most common types that contain undeclared drug ingredients,but drugs are showing up less in a third type that had been frequently found with drugs, bodybuilding supplements, says study in Journal of the American Medical Association. Researchers analyzing FDA database of tainted products marketed as supplements, say the trend didn't slow as FDA increased its GMP inspections and issued numerous warning letters.